Rocket Pharma annual meeting: all director nominees elected, auditor ratified, say-on-pay approved

ROCKET PHARMACEUTICALS, INC.

10 director nominees elected; David P. Southwell received 55.4M for vs 23.8M withheld, still elected on plurality standard.
Ratification of EisnerAmper as auditor approved with 90.7M votes for, 141.8K against, 528.3K abstentions.
Non-binding advisory vote on executive compensation passed with 77.2M for, 1.4M against, 515K abstentions.
Turnout of 91.4M shares (85.56% of eligible) voted at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.